Mild Cognitive Impairment

Research output: Chapter in Book/Report/Conference proceedingChapter

Abstract

The concept of mild cognitive impairment (MCI) as an intermediate state between normal cognition and dementia is a worthwhile construct in understanding functional decline in an ageing population. MCI is a relatively precise clinical diagnosis and a useful research tool. Individuals with MCI have (a) a subjective cognitive complaint that is usually corroborated by an informant, (b) preserved general cognitive functioning, (c) impairment in one or more of the cognitive domains (memory, attention-executive function, visuospatial skills and/or language) and (d) essentially normal activities of daily living. A number of aetiologies can be associated with MCI, including degenerative and vascular processes, psychiatric causes and comorbid medical conditions. The ultimate goal is to use this construct as a tool in developing treatments that will potentially prevent or delay the progression of dementia. Research is ongoing to determine factors that may predict this progression, with more recent studies combining data on clinical, genetic, neuroimaging and surrogate biomarkers.

Original languageEnglish (US)
Title of host publicationPathy's Principles and Practice of Geriatric Medicine: Fifth Edition
PublisherJohn Wiley and Sons
Pages881-893
Number of pages13
Volume2
ISBN (Print)9780470683934
DOIs
StatePublished - Mar 12 2012

Fingerprint

Dementia
Executive Function
Activities of Daily Living
Research
Neuroimaging
Cognition
Blood Vessels
Psychiatry
Language
Biomarkers
Cognitive Dysfunction
Population
Therapeutics

Keywords

  • Ageing
  • Alzheimer's disease
  • Cognitive dysfunction
  • Dementia
  • Functional impairment
  • MCI
  • Mild cognitive impairment
  • Predementia

ASJC Scopus subject areas

  • Medicine(all)

Cite this

Tangalos, E. G., & Petersen, R. C. (2012). Mild Cognitive Impairment. In Pathy's Principles and Practice of Geriatric Medicine: Fifth Edition (Vol. 2, pp. 881-893). John Wiley and Sons. https://doi.org/10.1002/9781119952930.ch74

Mild Cognitive Impairment. / Tangalos, Eric George; Petersen, Ronald Carl.

Pathy's Principles and Practice of Geriatric Medicine: Fifth Edition. Vol. 2 John Wiley and Sons, 2012. p. 881-893.

Research output: Chapter in Book/Report/Conference proceedingChapter

Tangalos, EG & Petersen, RC 2012, Mild Cognitive Impairment. in Pathy's Principles and Practice of Geriatric Medicine: Fifth Edition. vol. 2, John Wiley and Sons, pp. 881-893. https://doi.org/10.1002/9781119952930.ch74
Tangalos EG, Petersen RC. Mild Cognitive Impairment. In Pathy's Principles and Practice of Geriatric Medicine: Fifth Edition. Vol. 2. John Wiley and Sons. 2012. p. 881-893 https://doi.org/10.1002/9781119952930.ch74
Tangalos, Eric George ; Petersen, Ronald Carl. / Mild Cognitive Impairment. Pathy's Principles and Practice of Geriatric Medicine: Fifth Edition. Vol. 2 John Wiley and Sons, 2012. pp. 881-893
@inbook{e3eacbd7b6884eb089f6e87983b961ed,
title = "Mild Cognitive Impairment",
abstract = "The concept of mild cognitive impairment (MCI) as an intermediate state between normal cognition and dementia is a worthwhile construct in understanding functional decline in an ageing population. MCI is a relatively precise clinical diagnosis and a useful research tool. Individuals with MCI have (a) a subjective cognitive complaint that is usually corroborated by an informant, (b) preserved general cognitive functioning, (c) impairment in one or more of the cognitive domains (memory, attention-executive function, visuospatial skills and/or language) and (d) essentially normal activities of daily living. A number of aetiologies can be associated with MCI, including degenerative and vascular processes, psychiatric causes and comorbid medical conditions. The ultimate goal is to use this construct as a tool in developing treatments that will potentially prevent or delay the progression of dementia. Research is ongoing to determine factors that may predict this progression, with more recent studies combining data on clinical, genetic, neuroimaging and surrogate biomarkers.",
keywords = "Ageing, Alzheimer's disease, Cognitive dysfunction, Dementia, Functional impairment, MCI, Mild cognitive impairment, Predementia",
author = "Tangalos, {Eric George} and Petersen, {Ronald Carl}",
year = "2012",
month = "3",
day = "12",
doi = "10.1002/9781119952930.ch74",
language = "English (US)",
isbn = "9780470683934",
volume = "2",
pages = "881--893",
booktitle = "Pathy's Principles and Practice of Geriatric Medicine: Fifth Edition",
publisher = "John Wiley and Sons",

}

TY - CHAP

T1 - Mild Cognitive Impairment

AU - Tangalos, Eric George

AU - Petersen, Ronald Carl

PY - 2012/3/12

Y1 - 2012/3/12

N2 - The concept of mild cognitive impairment (MCI) as an intermediate state between normal cognition and dementia is a worthwhile construct in understanding functional decline in an ageing population. MCI is a relatively precise clinical diagnosis and a useful research tool. Individuals with MCI have (a) a subjective cognitive complaint that is usually corroborated by an informant, (b) preserved general cognitive functioning, (c) impairment in one or more of the cognitive domains (memory, attention-executive function, visuospatial skills and/or language) and (d) essentially normal activities of daily living. A number of aetiologies can be associated with MCI, including degenerative and vascular processes, psychiatric causes and comorbid medical conditions. The ultimate goal is to use this construct as a tool in developing treatments that will potentially prevent or delay the progression of dementia. Research is ongoing to determine factors that may predict this progression, with more recent studies combining data on clinical, genetic, neuroimaging and surrogate biomarkers.

AB - The concept of mild cognitive impairment (MCI) as an intermediate state between normal cognition and dementia is a worthwhile construct in understanding functional decline in an ageing population. MCI is a relatively precise clinical diagnosis and a useful research tool. Individuals with MCI have (a) a subjective cognitive complaint that is usually corroborated by an informant, (b) preserved general cognitive functioning, (c) impairment in one or more of the cognitive domains (memory, attention-executive function, visuospatial skills and/or language) and (d) essentially normal activities of daily living. A number of aetiologies can be associated with MCI, including degenerative and vascular processes, psychiatric causes and comorbid medical conditions. The ultimate goal is to use this construct as a tool in developing treatments that will potentially prevent or delay the progression of dementia. Research is ongoing to determine factors that may predict this progression, with more recent studies combining data on clinical, genetic, neuroimaging and surrogate biomarkers.

KW - Ageing

KW - Alzheimer's disease

KW - Cognitive dysfunction

KW - Dementia

KW - Functional impairment

KW - MCI

KW - Mild cognitive impairment

KW - Predementia

UR - http://www.scopus.com/inward/record.url?scp=84886179708&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84886179708&partnerID=8YFLogxK

U2 - 10.1002/9781119952930.ch74

DO - 10.1002/9781119952930.ch74

M3 - Chapter

AN - SCOPUS:84886179708

SN - 9780470683934

VL - 2

SP - 881

EP - 893

BT - Pathy's Principles and Practice of Geriatric Medicine: Fifth Edition

PB - John Wiley and Sons

ER -